AS206033
Repox Labs Ltd
AS206033 is Repox Labs Ltd (repoxlabs.com). It announces 512 IPv4 addresses in 2 prefixes, and 0 IPv6 prefixes.
United Kingdom· RIPE NCC· allocated 2025-07-30· Hosting
512
IPv4 addresses announced
2
IPv4 prefixes
0
IPv6 prefixes
50.00%
of its routes RPKI-valid
512
of its IPv4 geolocated
2
countries
Where its space is
The IPv4 it announces that IP Geolocation places, by country. A /24 counts for the AS announcing most of it.
- The Netherlands256 · 50.00%
- United States256 · 50.00%
Registry record
Its ASN Whois record, as the registry publishes it.
- handle
- REPOXLABS
- name
- Repox Labs Ltd
- org
- ORG-RLL4-RIPE
- org name
- Repox Labs Ltd
- org address
- 71-75 Shelton Street, Covent Garden, London
- org country
- GB
- country
- GB
- source
- ripe
- status
- ASSIGNED
- created
- 2025-07-30
- updated
- 2026-09-18
- maintainer
- RIPE-NCC-END-MNT|REPOXLABS-MNT
- abuse name
- Repox Labs Abuse Contact
- abuse email
- abuse@repoxlabs.com
- abuse kind
- role
What the databases see
Addresses each address-keyed database holds in the IPv4 it announces, as a share of that space, with its largest providers. Counts overlap.
- None here
- None here
- None here
- None here
- None here
- None here
- None here
- Hosting IP25650.00%
- None here
- None here
- None here
- None here
- SSH IP21541.99%
- None here
- 0.39%
- 0.39%
- None here
IPv4 prefixes
Every IPv4 prefix BGP Route saw it announce. A prefix another AS also announces says so.
| PREFIX | COUNTRY | RPKI | PEERS | FIRST SEEN |
|---|---|---|---|---|
| 104.233.185.0/24 | United States | Invalid, wrong origin | 1 | 2026-10-29 |
| 185.227.72.0/24 | The Netherlands | Valid | 17 | 2026-10-02 |
00 · Evaluate
Test the real build first.
An evaluation license puts a full current build in your hands, with no sampling, so you can measure it against your own traffic before anyone talks about terms.
01 · License
Then license what you use.
Standard, for detection and decisions inside your own product and operations.
Redistribution, when the data ships onward inside what you sell, priced by scope rather than by seat.
Annual terms, a named contact, and monthly, quarterly or yearly payment.